New designation is based on data showing rapid and durable responses in a heavily pretreated patient population and expands the promise of RYBREVANT FASPRO beyond lung ...
New designation is based on data showing rapid and durable responses in a heavily pretreated patient population and expands the promise of RYBREVANT ...
Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for subcutaneous amivantamab and hyaluronidase-lpuj as a ...
Monthly dosing reduces treatment visits while maintaining established safety and efficacy1,2 Builds on RYBREVANT FASPRO FDA approval to deliver the simplest and fastest ...
Due to rising cases among unvaccinated, young children, the UK has lost its measles elimination status - given to it by the World Health Organization (WHO). Cases of measles have also been rising in ...
CHILDREN face being forced to take three weeks off school in isolation as measles cases rip through the country. The warning ...
Allergic rhinitis shows dual effects on COVID 19 symptoms, while sublingual immunotherapy modifies respiratory and fever risk ...
SPARTANBURG, South Carolina >> About a dozen times each day, medical staff at Parkside Pediatrics in Spartanburg, South Carolina, head to the clinic’s parking lot, reaching inside cars and minivans to ...
The South Carolina outbreak has surpassed 930 cases, about 20 of which required hospitalization, according to state health officials. No deaths have been reported by the state ...
(THE CONVERSATION) The measles outbreak in South Carolina reached 876 cases on Feb. 3, 2026. That number surpasses the 2025 outbreak in Texas and hits the unfortunate milestone of being the largest ...
An FDA database analysis shows that reported adverse skin events after GLP-1 receptor agonist use are rare but can include rash and pruritus, highlighting a need for further research, according to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results